1. Please check and comment entries here.
Table of Contents

    Topic review


    View times: 6
    Submitted by: FNU RAVINDER KUMAR


    Shugoshin (meaning “guardian spirit” in Japanese) is a homo-dimeric phospho-protein belonging to the shugoshin protein family. Shugoshin is conserved from single-celled yeast to multicellular mammals including humans. Shugoshin shares several structural features with other members of the shugoshin family, including a basic region at the C-terminus that is essential for centromere binding, chromosome localization, and an N-terminal coiled-coil domain that may regulate its dimerization and interaction with other proteins.

    1. Introduction

    Proper cell division is a foremost requirement for reproduction as well as for the survival and continuity of every species. Mis-segregation of the genome during cell division leads to aneuploidy, which is closely associated with numerous medical consequences ranging from tumorigenesis to sterility, mental retardation, spontaneous abortion, and other birth-related defects [1][2][3][4][5][6]. To ensure that the genetic blueprint is duplicated and distributed precisely during cell division, cells employ several mechanisms operating either independently or in coordination with one another. Proper and timely removal of cohesin is an example of one such mechanism. Cohesin, a multiprotein complex, holds sister chromatids together from DNA duplication in S-phase until the onset of anaphase. The premature or untimely loss of cohesion as a result of abrupt separase activity leads to chromosome mis-segregation. Hence, cohesin cleavage by separase is kept under tight cellular control [7][8]. Apart from its prime role of holding sister chromatids together, cohesin is also known for its involvement in diverse cellular processes discussed elsewhere [9]. A detailed account of cohesin and separase falls outside the scope of the present review, and these aspects are summarized elsewhere [8][10]. Apart from the timely cleavage of cohesin, several other mechanisms including DNA damage checkpoint (DDC), spindle assembly checkpoint (SAC), separase activation, and centriole duplication (and maybe more which remain unidentified) ensure that the genetic endowment of the cell or organism, i.e., its genome is duplicated and separated properly. A detailed discussion of all such mechanisms is difficult in the present review, may require a separate volume, and can be found elsewhere [8][11][12][13][14][15][16].

    2. Shugoshin Background

    Shugoshin (meaning “guardian spirit” in Japanese) is a homo-dimeric phospho-protein belonging to the shugoshin protein family [17][18]. Shugoshin is conserved from single-celled yeast to multicellular mammals including humans. Shugoshin shares several structural features with other members of the shugoshin family, including a basic region at the C-terminus that is essential for centromere binding, chromosome localization, and an N-terminal coiled-coil domain that may regulate its dimerization and interaction with other proteins [19][20][21][22]. Initially, shugoshin was discovered in the fruit fly, D. melanogaster , as a peri-centromeric protein (at the time referred to as MEI-S332) required for the protection of Rec8 (meiotic-specific cohesin subunit) from separase action and its persistence during meiosis-I [23][24][25]. Later, a protein factor with a function equivalent to MEI-S332 was discovered in other eukaryotic species including yeast, insects, vertebrates, and plants [26][27][28][29][30][31].

    Based on the sequence (at the gene and protein levels) and structural analysis, it has been observed that all eukaryotic species studied to date possess either one or two genes coding for shugoshin (referred to as SGO1 and SGO2 ), although several splicing isoforms of shugoshin have been reported in higher eukaryotes [32]. Table 1 shows the number of genes coding for shugoshin in different species. The reason why some species (for example, Saccharomyces cerevisiae ) possess only one gene for shugoshin and others two (for example, fission yeast, humans) remains elusive. In human cells, a combined total of 10 splicing isoforms (for SGO1 and SGO2 ) have been identified ( http://www.uniprot.org/uniprot/?query=hugoshin%2C+homo+sapiens&sort=score (accessed on 4 March 2021)). Information related to different isoforms of human SGO1 and SGO2 , including the number of amino acid residues and molecular mass, is given in Table 2 . The size or number of amino acid residues in shugoshin and molecular mass vary significantly across different eukaryotic species [31] as well as among different isoforms within the same species (for example, Homo sapiens , Table 2 ). It is important to mention that different shugoshin paralogs are known to exhibit different properties depending on the species under consideration. The expression pattern or profile of shugoshin paralogs may be cell cycle-dependent (i.e., mitosis or meiosis). For example, in fission yeast SGO2 is expressed in both mitosis and meiosis while SGO1 is meiosis-specific [26]. Like fission yeast, mouse SGO2 is required for the completion of meiosis but not for mitosis, suggesting its cell cycle-specific expression [33].

    Table 1. Number of genes coding for shugoshin in different species.

    Species No. of Genes Kingdom References
    Saccharomyces cerevisiae 1 Fungi *
    Schizosaccharomyces pombe 2 Fungi *
    Mus musculus 2 Animalia Uniprot
    Arabidopsis thialana 2 Plantae Uniprot
    §Homo sapiens 2 Animalia Uniprot
    Drosophila melanogaster 1 Animalia Uniprot
    Caenorhabditis elegence 1 Animalia Uniprot
    Oryza sativa 1 Plantae Uniprot
    Xenopus laevis 1 Animalia Uniprot
    Neurospora crassa 1 Fungi Uniprot
    Danio rerio 1 Animalia Uniprot
    Zea mays 1 Plantae Uniprot
    Rattus norvegicus 1 Animalia Uniprot
    Candida glabrata 1 Fungi *
    Kluyveromyces lactis 1 Fungi *
    Aphis gossypii 1 Fungi *
    Pristionchus pacificus 1 Animalia Uniprot
    Oryzias latipes 1 Animalia Uniprot
    Candida albicans 1 Fungi *

    * https://portals.broadinstitute.org/cgibin/regev/orthogroups/show_orthogroup.cgi?orf=YOR073W (accessed on 8 August 2019). Uniprot (www.uniprot.org/uniprot (accessed on 8 August 2019)). § Total of ten isoforms have been reported in humans.

    Table 2. Size and molecular mass of different isoforms of human SGO1 and SGO2.

    Shugoshin Isoform Number of Amino Acid Residues Mol. Mass (in kDa) Identifier
    * SGO1 Isoform 1 561 64.19 Q5FBB7-1
      Isoform 2 309 35.344 Q5FBB7-2
      Isoform 3 292 33.501 Q5FBB7-3
      Isoform 4 275 31.276 Q5FBB7-4
      Isoform 5 258 29.433 Q5FBB7-5
      Isoform 6 527 60.122 Q5FBB7-6
      Isoform 7 215 24.646 Q5FBB7-7
    ! SGO2 Isoform 1 1265 144.739 Q562F6-1
      Isoform 2 1261 144.181 Q562F6-2
      Isoform 3 247 28.23 Q562F6-3
    *https://www.uniprot.org/uniprot/Q5FBB7 (accessed on 4 March 2021). ! https://www.uniprot.org/uniprot/Q562F6 (accessed on 4 March 2021).

    Shugoshin is present in all the eukaryotic species studied to date, and shugoshin-based protection of centromeric cohesin is conserved across different eukaryotic species. However, the cells of C. elegans use a different strategy that is independent of shugoshin. Unlike other species, chromosome segregation in C. elegans relies on an alternative mechanism that involves LAB-1 (Long Arm of the Bivalent) [34]. This study in C. elegans raised the possibility of shugoshin-independent cohesin protection in other species. Why the cells of C. elegans use this alternative mechanism despite the presence of shugoshin remains an open question. Whether shugoshin-independent protection of centromeric cohesin is exclusive to worm species also remains a matter for future investigation.

    3. Shugoshin as a Tumor-Associated Gene

    A decreased level or complete absence of shugoshin has been observed in head and neck cancer [35], nasopharyngeal carcinoma [36], neuroblastoma [37], and prostate cancer [38][39]. Homozygous deletion of SGOL2 has been observed in different types of human tumors including head and neck cancer [40], small-cell lung carcinoma [41], cervical carcinoma [42], and neuroblastoma [43]. It is important to mention that deletion of either allele of shugoshin (i.e., SGOL1 or SGOL2 for shugoshin in humans) can lead to cancer. Among 46 colorectal cancer cases, hSgo1 mRNA expression was decreased in the tumor tissue compared with the corresponding normal tissue [44]. Heterozygous deletion of sgo1 +/− leads to systemic chromosome instability in mice [45] and the formation of aberrant crypt foci (ACF) in mice heterozygous for shugoshin-1 [46]. Treatment with the carcinogen azoxymethane (oxide of azomethane, a carcinogenic and neurotoxic chemical compound used in biological research) caused sgo1 +/− ME-CIN model mice to develop hepatocellular carcinoma (HCC) within 6 months; in contrast, control mice developed no HCC ( p < 0.003) [47].

    In the last section, we mentioned some of the studies where shugoshin behaved as a tumor suppressor gene. In this section, we will mention some of the studies which showed the oncogenic behavior of shugoshin. Upregulated expression of shugoshin was observed in 82% of hepatocellular carcinoma (HCC) cases and correlated with elevated alpha-fetoprotein and early disease onset of HCC, while depletion of shugoshin-1 reduced the cell viability of hepatoma cell lines including HuH7, HepG2, Hep3B, and HepaRG due to persistent activation of the spindle assembly checkpoint [48]. Increased expression and level of shugoshin were reported in human leukemia [49] and breast cancers [50][51]. Similarly, overexpression of SGOL1-B1 in a non-small-cell lung carcinoma (NSCLC) cell line induced aberrant chromosome mis-segregation, precociously separated chromatids, and delayed mitotic progression. A higher level of SGO1-B mRNA was related to taxane (diterpenes, compounds originally identified in the plant genus Taxus (yews), used in cancer chemotherapy, e.g., paclitaxel and docetaxel) resistance, while the forced downregulation of SGO1-B increased the sensitivity to taxane [52]. Expression of SGO1C (a non-functional isoform of shugoshin) alone induced aberrant mitosis similar to depletion of SGO1A , promoting premature sister chromatid separation, activation of the spindle assembly checkpoint, and mitotic arrest, suggesting that the expression of SGO1C is tightly regulated to prevent dominant-negative effects of SGO1A and genome instability [53]. In another clinical study, the expression of SGO1 in human prostate tumors was higher than that of adjacent normal tissues and was positively correlated with the poor prognosis of prostate cancer patients [54]. Some of the studies mentioned above clearly showed the oncogenic nature of shugoshin.

    Not only complete loss of shugoshin but also an altered level of shugoshin can lead to cancer. Whether shugoshin’s association with cancer is due to chromosome mis-segregation or due to derailment of other cellular pathways resulting from a complete absence or altered level of shugoshin remains a topic for future research. Because an altered shugoshin level is associated with various cancers, and chemicals (for example, BPA or Bisphenol A, used as a plasticizer in plastic industries) can potentially alter its expression, it is possible that increased incidences of tumors and associated altered shugoshin levels may be linked and require further research [55]. The identification of chemicals that can modulate the transcription of shugoshin and other tumor-associated genes can be an important field for future research.

    The entry is from 10.3390/biochem1020006


    1. Rajagopalan, H.; Lengauer, C. Aneuploidy and cancer. Nature 2004, 432, 338–341.
    2. Hassold, T.; Hall, H.; Hunt, P. The origin of human aneuploidy: Where we have been, where we are going. Hum. Mol. Genet. 2007, 16, 203–208.
    3. Jallepalli, P.V.; Lengauer, C. Chromosome segregation and cancer: Cutting through the mystery. Nat. Rev. Cancer 2001, 1, 109–117.
    4. Lengauer, C.; Kinzler, K.W.; Vogelstein, B. Genetic instability in colorectal cancers. Nature 1997, 386, 623–627.
    5. Griffin, D.K. The incidence, origin, and etiology of aneuploidy. Int. Rev. Cytol. 1996, 167, 263–296.
    6. Sen, S. Aneuploidy and cancer. Curr. Opin. Oncol. 2000, 12, 82–88.
    7. Uhlmann, F. Secured cutting: Controlling separase at the metaphase to anaphase transition. EMBO Rep. 2001, 2, 487–492.
    8. Kumar, R. Separase: Function Beyond Cohesion Cleavage and an Emerging Oncogene. J. Cell Biochem. 2017, 118, 1283–1299.
    9. Mehta, G.D.; Kumar, R.; Srivastava, S.; Ghosh, S.K. Cohesin: Functions beyond sister chromatid cohesion. FEBS Lett. 2013, 587, 2299–2312.
    10. Nasmyth, K.; Haering, C.H. Cohesin: Its roles and mechanisms. Annu. Rev. Genet. 2009, 43, 525–558.
    11. Joglekar, A.P. A Cell Biological Perspective on Past, Present and Future Investigations of the Spindle Assembly Checkpoint. Biology 2016, 5, 44.
    12. Kamenz, J.; Hauf, S. Time to Split up: Dynamics of Chromosome Separation. Trends Cell Biol. 2017, 27, 42–54.
    13. Fujita, H.; Yoshino, Y.; Chiba, N. Regulation of the centrosome cycle. Mol. Cell Oncol. 2015, 3, e1075643.
    14. Simpson-Lavy, K.J.; Oren, Y.S.; Feine, O.; Sajman, J.; Listovsky, T.; Brandeis, M. Fifteen years of APC/cyclosome: A short and impressive biography. Biochem. Soc. Trans. 2010, 38, 78–82.
    15. Agarwal, M.; Mehta, G.; Ghosh, S.K. Role of Ctf3 and COMA subcomplexes in meiosis: Implication in maintaining Cse4 at the centromere and numeric spindle poles. Biochim. Biophys. Acta Mol. Cell Res. 2015, 1853, 671–684.
    16. Agarwal, M.; Jin, H.; McClain, M.; Fan, J.; Koch, B.A.; Jaspersen, S.L.; Yu, H.G. The half-bridge component Kar1 promotes centrosome separation and duplication during budding yeast meiosis. Mol. Biol. Cell 2018, 29, 1798–1810.
    17. Xu, Z.; Cetin, B.; Anger, M.; Cho, U.S.; Helmhart, W.; Nasmyth, K.; Xu, W. Structure and function of the PP2A-shugoshin inter-action. Mol. Cell 2009, 35, 426–441.
    18. Swaney, D.L.; Beltrao, P.; Starita, L.; Guo, A.; Rush, J.; Fields, S.; Krogan, N.J.; Villén, J. Global analysis of phosphorylation and ubiquitylation crosstalk in protein degradation. Nat. Methods 2013, 10, 676–682.
    19. Tang, T.T.; Bickel, S.E.; Young, L.M.; Orr-Weaver, T.L. Maintenance of sister-chromatid cohesion at the centromere by the Drosophila MEI-S332 protein. Genes Dev. 1998, 12, 3843–3856.
    20. Watanabe, Y. Shugoshin: Guardian spirit at the centromere. Curr. Opin. Cell Biol. 2005, 17, 590–595.
    21. Watanabe, Y.; Kitajima, T.S. Shugoshin protects cohesin complexes at centromeres. Philos. Trans. R. Soc. B Biol. Sci. 2005, 360, 515–521.
    22. Watanabe, Y. Temporal and spatial regulation of targeting aurora B to the inner centromere. Cold Spring Harb. Symp. Quant. Biol. 2010, 75, 419–423.
    23. Davis, B.K. A analysis of a meiotic mutant resulting in precocious sister-centromere separation in Drosophila melanogaster. Mol. Gen. Genet. 1971, 113, 251–272.
    24. Kerrebrock, A.W.; Miyazaki, W.Y.; Birnby, D.; Orr-Weaver, T.L. The Drosophila mei-S332 gene promotes sister-chromatid cohesion in meiosis following kinetochore differentiation. Genetics 1992, 130, 827–841.
    25. Kerrebrock, A.; Moore, D.; Wu, J.; Orr-Weaver, T. Mei-S332, a Drosophila protein required for sister-chromatid cohesion, can localize to meiotic centromere regions. Cell 1995, 83, 247–256.
    26. Kitajima, T.S.; Kawashima, S.A.; Watanabe, Y. The conserved kinetochore protein shugoshin protects centromeric cohesion during meiosis. Nature 2004, 427, 510–517.
    27. Katis, V.L.; Galova, M.; Rabitsch, K.P.; Gregan, J.; Nasmyth, K. Maintenance of cohesin at centromeres after meiosis I in budding yeast requires a kinetochore-associated protein related to MEI-S332. Curr. Biol. 2004, 14, 560–572.
    28. Marston, A.L.; Tham, W.H.; Shah, H.; Amon, A. A genome-wide screen identifies genes required for centromeric cohesion. Science 2004, 303, 1367–1370.
    29. Rabitsch, K.P.; Gregan, J.; Schleiffer, A.; Javerzat, J.P.; Eisenhaber, F.; Nasmyth, K. Two fission yeast homologs of Drosophila Mei-S332 are required for chromosome segregation during meiosis-I and II. Curr. Biol. 2004, 14, 287–301.
    30. Hamant, O.; Golubovskaya, I.; Meeley, R.; Fiume, E.; Timofejeva, L.; Schleiffer, A.; Nasmyth, K.; Cande, W.Z. A REC8-dependent plant Shugoshin is required for maintenance of centromeric cohesion during meiosis and has no mitotic functions. Curr. Biol. 2005, 15, 948–954.
    31. Wang, M.; Tang, D.; Wang, K.; Shen, Y.; Qin, B.; Miao, C.; Li, M.; Cheng, Z. OsSGO1 maintains synaptonemal complex stabilization in addition to protecting centromeric cohesion during rice meiosis. Plant J. 2011, 67, 583–594.
    32. Yao, Y.; Dai, W. Shugoshins function as a guardian for chromosomal stability in nuclear division. Cell Cycle 2012, 11, 2631–2642.
    33. Llano, E.; Gómez, R.; Gutiérrez-Caballero, C.; Herrán, Y.; Sánchez-Martín, M.; Vázquez-Quiñones, L.E.; Hernández, T.; de Álava, E.; Cuadrado, A.; Barbero, J.; et al. Shugoshin-2 is essential for the completion of meiosis but not for mitotic cell division in mice. Genes Dev. 2008, 22, 2400–2413.
    34. de Carvalho, C.E.; Zaaijer, S.; Smolikov, S.; Gu, Y.; Schumacher, J.M.; Colaiácovo, M.P. LAB-1 antagonizes the Aurora B kinase in C. elegans. Genes Dev. 2008, 22, 2869–2885.
    35. Coon, S.W.; Savera, A.T.; Zarbo, R.J.; Benninger, M.S.; Chase, G.A.; Rybicki, B.A.; Van Dyke, D.L. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma. Int. J. Cancer 2004, 111, 206–212.
    36. Shao, J.Y.; Wang, H.Y.; Huang, X.M.; Feng, Q.S.; Huang, P.; Feng, B.J.; Huang, L.X.; Yu, X.J.; Li, J.T.; Hu, L.F.; et al. Genome-wide allele type analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int. J. Oncol. 2000, 17, 1267–1275.
    37. Altura, R.A.; Maris, J.M.; Li, H.; Boyett, J.M.; Brodeur, G.M.; Look, A.T. Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization. Genes Chromosomes Cancer 1997, 19, 176–184.
    38. Pallai, R.; Bhaskar, A.; Barnett-Bernodat, N.; Gallo-Ebert, C.; Nickels, J.T., Jr.; Rice, L.M. Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin. Tumor Biol. 2015, 36, 6067–6074.
    39. Dahiya, R.; McCarville, J.; Hu, W.; Lee, C.; Chui, R.M.; Kaur, G.; Deng, G. Chromosome 3p24–26 and 3p22–12 loss in human prostatic adenocarcinoma. Int. J. Cancer 1997, 71, 20–25.
    40. Beder, L.B.; Gunduz, M.; Ouchida, M.; Fukushima, K.; Gunduz, E.; Ito, S.; Sakai, A.; Nagai, N.; Nishizaki, K.; Shimizu, K. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab. Investig. 2003, 83, 99–105.
    41. Kohno, T.; Morishita, K.; Takano, H.; Shapiro, D.N.; Yokota, J. Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. Oncogene 1994, 9, 103–108.
    42. Rader, J.S.; Kamarasova, T.; Huettner, P.C.; Li, L.; Li, Y.; Gerhard, D.S. Allelotyping of all chromosomal arms in invasive cervical cancer. Oncogene 1996, 13, 2737–2741.
    43. Takita, J.; Yang, H.W.; Chen, Y.Y.; Hanada, R.; Yamamoto, K.; Teitz, T.; Kidd, V.; Hayashi, Y. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 2001, 20, 4424–4432.
    44. Iwaizumi, M.; Shinmura, K.; Mori, H.; Yamada, H.; Suzuki, M.; Kitayama, Y.; Igarashi, H.; Nakamura, T.; Suzuki, H.; Watanabe, Y.; et al. Human Sgo1 downregulation leads to chromosomal instability in colorectal cancer. Gut 2009, 58, 249–260.
    45. Rao, C.V.; Sanghera, S.; Zhang, Y.; Biddick, L.; Reddy, A.; Lightfoot, S.; Janakiram, N.B.; Mohammed, A.; Dai, W.; Yamada, H.Y. Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice. Cancer Res. 2016, 76, 630–642.
    46. Rao, C.V.; Sanghera, S.; Zhang, Y.; Biddick, L.; Reddy, A.; Lightfoot, S.; Dai, W.; Yamada, H.Y. Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model. Mol. Carcinog. 2016, 55, 600–610.
    47. Yamada, H.Y.; Zhang, Y.; Reddy, A.; Mohammed, A.; Lightfoot, S.; Dai, W.; Rao, C.V. Tumor-promoting/progressing role of additional chromosome instability in hepatic carcinogenesis in Sgo1 (Shugoshin 1) haploinsufficient mice. Carcinogenesis 2015, 36, 429–440.
    48. Wang, L.H.; Yen, C.J.; Li, T.N.; Elowe, S.; Wang, W.C.; Wang, L.H. Sgo1 is a potential therapeutic target for hepatocellular carcinoma. Oncotarget 2015, 6, 2023–2033.
    49. Yang, J.; Ikezoe, T.; Nishioka, C.; Yokoyama, A. A novel treatment strategy targeting shugoshin 1 in hematological malignancies. Leuk. Res. 2013, 37, 76–82.
    50. Scanlan, M.J.; Gout, I.; Gordon, C.M.; Williamson, B.; Stocker Et Gure, A.O.; Jager, D.; Chen, Y.T.; Mackay, A.; O’Hare, M.J.; Old, L.J. Humoral immunity to human breast cancer: Antigen definition and quantitative analysis of mRNA expression. Cancer Immun. 2001, 1, 4.
    51. Yang, Q.; Yoshimura, G.; Nakamura, M.; Nakamura, Y.; Shan, L.; Suzuma, T.; Tamaki, T.; Umemura, T.; Mori, I.; Kakudo, K. Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta2 expression in breast carcinoma. Breast Cancer Res. Treat. 2011, 70, 39–45.
    52. Matsuura, S.; Kahyo, T.; Shinmura, K.; Iwaizumi, M.; Yamada, H.; Funai, K.; Kobayashi, J.; Tanahashi, M.; Niwa, H.; Ogawa, H.; et al. SGOL1 variant B induces abnormal mitosis and resistance to taxane in non-small cell lung cancers. Sci. Rep. 2013, 3, 3012.
    53. Wong, W.K.; Kelly, T.; Li, J.; Ma, H.T.; Poon, R.Y. SGO1C is a non-functional isoform of Shugoshin and can disrupt sister chromatid cohesion by interacting with PP2A-B56. Cell Cycle 2015, 14, 3965–3977.
    54. Chen, Q.; Wan, X.; Chen, Y.; Liu, C.; Gu, M.; Wang, Z. SGO1 induces proliferation and metastasis of prostate cancer through AKT-mediated signaling pathway. Am. J. Cancer Res. 2019, 9, 2693–2705.
    55. Ribeiro-Varandas, E.; Viegas, W.; Sofia Pereira, H.; Delgado, M. Bisphenol A at concentrations found in human serum induces aneugenic effects in endothelial cells. Mutat. Res. 2013, 751, 27–33.